The company has completed the Research and Development of more than 100 products and transformed them into APIs and intermediates, of which 90 products have the capacity for industrial production. The varities of these products cover anti-tumor, diabetes, immune diseases, mental depression, antibacterial and antiviral, cardiovascular and cerebrovascular diseases, etc.